iDC-targeting PfCSP mRNA vaccine confers superior protection against Plasmodium compared to conventional mRNA

Related articles

1. Repurposed endogenous virus-like vesicles mediate dendritic cell long-range antigen presentation and T-cell activation for enhanced cancer vaccination

   This article has 21 authors:

   1. Shaoyi Jiang
   2. Wenchao Gu
   3. Ruoxin Li
   4. Hayleigh Goodrich
   5. Dorin Artzi
   6. Simian Cai
   7. Yi-Chih Tsai
   8. Aixin Shi
   9. Ann Li
   10. Guoting Qin
   11. Nadine Elkasri
   12. Evelyn Goldwasser
   13. Sijin Luo Zhong
   14. Vaibhav Upadhayay
   15. Yu Zhao
   16. Yating Yang
   17. Justin Lau
   18. Ella Sultan
   19. Alexei Wirganowicz
   20. Chengzhi Cai
   21. Qiuming Yu

2. Infant CD4 T-cell response to SARS-CoV-2 mRNA vaccination is restricted in cytokine production and modified by vaccine manufacturer

   This article has 13 authors:

   1. M Quinn Peters
   2. Amber L. Young
   3. Jennifer E. Stolarczuk
   4. Madeline Glad
   5. Erik Layton
   6. Jennifer K. Logue
   7. Nana K. Minkah
   8. Helen Y. Chu
   9. Janet A. Englund
   10. D. Noah Sather
   11. Chetan Seshadri
   12. Alisa Kachikis
   13. Whitney E. Harrington

3. Intranasal sarbecovirus vaccine booster elicits cross-clade, durable and protective systemic and mucosal immunity

   This article has 12 authors:

   1. Nicholas You Zhi Cheang
   2. Wee Chee Yap
   3. Kirsteen McInnes Tullett
   4. Xinlei Qian
   5. Peck Szee Tan
   6. Kiren Purushotorman
   7. Wan Yi Tan
   8. Shirley Yun Yan Mah
   9. Paul Anthony Macary
   10. Chee Wah Tan
   11. Mireille Hanna Lahoud
   12. Sylvie Alonso